Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman M Kneteman

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|January 20, 2009
Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients databaseChristian Toso, Sonal Asthana, David L Bigam, et al.
Hepatology (Baltimore, Md.)|February 27, 2010
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinomaChristian Toso, Shaheed Merani, David L Bigam, et al.
Clinical Transplantation|April 9, 2014
Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: refined selection criteriaSamy Kashkoush, Walid El Moghazy, Toshiyasu Kawahara, et al.
Journal of Hepatology|February 22, 2011
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinomaShaheed Merani, Pietro Majno, Norman M Kneteman, et al.
Cellular Signalling|August 19, 2007
Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cellsPeng Wang, Jing Zhang, Anita Bellail, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|January 25, 2011
The impact of sirolimus on hepatitis C recurrence after liver transplantationSonal Asthana, Christian Toso, Glenda Meeberg, et al.
Journal of Critical Care|May 27, 2014
Respiratory rate at intensive care unit discharge after liver transplant is an independent risk factor for intensive care unit readmission within the same hospital stay: a nested case-control studyFilipe S Cardoso, Constantine J Karvellas, Norman M Kneteman, et al.
Canadian Journal of Gastroenterology & Hepatology|May 13, 2015
Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort studyFilipe S Cardoso, Constantine J Karvellas, Norman M Kneteman, et al.
Plos Pathogens|April 13, 2012
Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiationXianfang Wu, Jason M Robotham, Emily Lee, et al.
Hepatology (Baltimore, Md.)|March 18, 2015
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validationChristian Toso, Glenda Meeberg, Roberto Hernandez-Alejandro, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|January 20, 2009
Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients databaseChristian Toso, Sonal Asthana, David L Bigam, et al.
Hepatology (Baltimore, Md.)|February 27, 2010
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinomaChristian Toso, Shaheed Merani, David L Bigam, et al.
Clinical Transplantation|April 9, 2014
Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: refined selection criteriaSamy Kashkoush, Walid El Moghazy, Toshiyasu Kawahara, et al.
Journal of Hepatology|February 22, 2011
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinomaShaheed Merani, Pietro Majno, Norman M Kneteman, et al.
Cellular Signalling|August 19, 2007
Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cellsPeng Wang, Jing Zhang, Anita Bellail, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|January 25, 2011
The impact of sirolimus on hepatitis C recurrence after liver transplantationSonal Asthana, Christian Toso, Glenda Meeberg, et al.
Journal of Critical Care|May 27, 2014
Respiratory rate at intensive care unit discharge after liver transplant is an independent risk factor for intensive care unit readmission within the same hospital stay: a nested case-control studyFilipe S Cardoso, Constantine J Karvellas, Norman M Kneteman, et al.
Canadian Journal of Gastroenterology & Hepatology|May 13, 2015
Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort studyFilipe S Cardoso, Constantine J Karvellas, Norman M Kneteman, et al.
Plos Pathogens|April 13, 2012
Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiationXianfang Wu, Jason M Robotham, Emily Lee, et al.
Hepatology (Baltimore, Md.)|March 18, 2015
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validationChristian Toso, Glenda Meeberg, Roberto Hernandez-Alejandro, et al.
Pageof 9